BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2121362)

  • 1. [The effect of 1,25-dihydroxycholecalciferol on immunity and the clinical state and on parameters of phospho-calcium metabolism in dialyzed patients].
    Bartůnková J; Sulková S; Fucíková T; Marecková H; Válek A
    Cas Lek Cesk; 1990 Aug; 129(35):1102-6. PubMed ID: 2121362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative changes in cell-mediated immunity in patients with chronic renal failure].
    Nakagawa H; Hosokawa T; Hori Y; Hashimoto T; Yoda K; Miyazaki M
    Masui; 1989 Dec; 38(12):1574-82. PubMed ID: 2533280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of calcium acetate as a chelating of phosphorus in patients in hemodialysis with secondary hyperthyroidism].
    Torregrosa Prats JV; Mas Mas M; Montesinos Ballestena M; Casellas Bartumeus J; Campistol Plana JM
    An Med Interna; 1995 Aug; 12(8):377-81. PubMed ID: 8924527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of arterial compliance in patients treated by hemodialysis.
    Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
    Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.
    Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
    J Am Soc Nephrol; 2005 Sep; 16(9):2796-803. PubMed ID: 16049067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of single-needle versus double-needle hemodialysis in chronic renal failure.
    Trakarnvanich T; Chirananthavat T; Ariyakulnimit S; Maneerat P; Chabsuwan S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S196-206. PubMed ID: 17044473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
    J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
    Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
    Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
    Wadhwa NK; Suh H; Howell N; Cabralda T; Sokunbi D; Solomon M
    Adv Perit Dial; 1993; 9():260-3. PubMed ID: 8105939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
    Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
    Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
    Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
    Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
    Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.